Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation
PharmaVoice,
Source: Novartis Data demonstrate Novartis’ unwavering commitment to reimagining cancer care for patients in the UK in advanced…